Pseudo-Richter transformation in a patient with chronic lymphocytic leukemia after cessation of fixed duration venetoclax/ibrutinib treatment
Annals of Hematology · 20.05.2026 · 105 (8)
DOI: 10.1007/s00277-026-07069-y ↗Kurz gefasst
Fallbericht in der Zeitschrift Annals of Hematology, online erschienen am 20.05.2026. Verfasst von Raphael Battegay und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of hematology, University Hospital Basel, Basel, Switzerland. Raphael.battegay@usb.ch. Hauptthemen laut MEDLINE: Leukemia, Lymphocytic, Chronic, B-Cell, Bridged Bicyclo Compounds, Heterocyclic, Adenine, Sulfonamides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of hematology, University Hospital Basel, Basel, Switzerland. Raphael.battegay@usb.ch.
- Department of hematology, Basel University Hospital, Petersgraben 4, Basel, 4031, Switzerland. Raphael.battegay@usb.ch.
- Department of hematology, University Hospital Basel, Basel, Switzerland.
- Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.
Zitieren
APA
Battegay, R., Heim, D., & Dirnhofer, S. (2026). Pseudo-Richter transformation in a patient with chronic lymphocytic leukemia after cessation of fixed duration venetoclax/ibrutinib treatment. Annals of Hematology, 105(8). https://doi.org/10.1007/s00277-026-07069-y
Vancouver
Battegay R, Heim D, Dirnhofer S. Pseudo-Richter transformation in a patient with chronic lymphocytic leukemia after cessation of fixed duration venetoclax/ibrutinib treatment. Annals of Hematology. 2026;105(8). doi:10.1007/s00277-026-07069-y
BibTeX
@article{Battegay2026,
author = {Battegay, Raphael and Heim, Dominik and Dirnhofer, Stefan},
title = {Pseudo-Richter transformation in a patient with chronic lymphocytic leukemia after cessation of fixed duration venetoclax/ibrutinib treatment},
journal = {Annals of Hematology},
year = {2026},
volume = {105},
number = {8},
doi = {10.1007/s00277-026-07069-y}
}
EUVIMED